Acute Lymphoblastic Leukemia Therapy
New acute lymphoblastic leukemia therapy research reported from Dana-Farber Cancer Institute, Department of Medical Oncology
Published in Blood Weekly, July 19th, 2007
Fresh data on acute lymphoblastic leukemia are presented in the report "Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801." According to recent research published in the journal Blood, "Nelarabine (506U78) is a soluble pro-drug of 9-beta-D-arabinofuranosylguanine (ara-G), a deoxyguanosine derivative. We treated 26 patients with T-cell acute lymphoblastic leukemia (T-ALL) and 13 with T-cell lymphoblastic lymphoma (T-LBL) with nelarabine."
"All patients were refractory to at least one multiagent regimen or had relapsed after achieving...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-07-19)
More Articles from Blood Weekly
- Biochips
Progenika Biopharma presents a biochip that guarantees safety in blood transfusions - Liver Transplants
Cardiac surgery in patients with liver cirrhosis - Blood Cancer
School's Out for Summer - and the Final Tally's in: U.S. Students Raised $18 Million in the Fight Against Blood Cancer - Cancer
The Children's Hospital at Montefiore Receives $12 Million Gift From Jerome L. Greene Foundation - Clinical Trial Research
Isotechnika achieves full enrolment for ISA247 Phase 2b kidney transplant trial - Cord Blood
Cord Blood America Announces Retirement of Registered Convertible Debt - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
